JPH04263854A - Wound coating material - Google Patents
Wound coating materialInfo
- Publication number
- JPH04263854A JPH04263854A JP11123791A JP11123791A JPH04263854A JP H04263854 A JPH04263854 A JP H04263854A JP 11123791 A JP11123791 A JP 11123791A JP 11123791 A JP11123791 A JP 11123791A JP H04263854 A JPH04263854 A JP H04263854A
- Authority
- JP
- Japan
- Prior art keywords
- porous
- wound
- membrane
- polyolefin membrane
- porosity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000463 material Substances 0.000 title claims abstract description 20
- 239000011248 coating agent Substances 0.000 title abstract description 3
- 238000000576 coating method Methods 0.000 title abstract description 3
- 229920001477 hydrophilic polymer Polymers 0.000 claims abstract description 5
- 239000012528 membrane Substances 0.000 claims description 43
- 229920000098 polyolefin Polymers 0.000 claims description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 238000010559 graft polymerization reaction Methods 0.000 claims description 7
- 230000035699 permeability Effects 0.000 claims description 6
- 125000005396 acrylic acid ester group Chemical group 0.000 claims description 2
- -1 polyethylene Polymers 0.000 abstract description 9
- 230000008929 regeneration Effects 0.000 abstract description 5
- 238000011069 regeneration method Methods 0.000 abstract description 5
- 239000004743 Polypropylene Substances 0.000 abstract description 4
- 229920001155 polypropylene Polymers 0.000 abstract description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 abstract description 2
- 239000004709 Chlorinated polyethylene Substances 0.000 abstract description 2
- 239000002033 PVDF binder Substances 0.000 abstract description 2
- 239000004698 Polyethylene Substances 0.000 abstract description 2
- 229920001328 Polyvinylidene chloride Polymers 0.000 abstract description 2
- 229920001577 copolymer Polymers 0.000 abstract description 2
- 229920000573 polyethylene Polymers 0.000 abstract description 2
- 239000005033 polyvinylidene chloride Substances 0.000 abstract description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 abstract description 2
- 206010052428 Wound Diseases 0.000 description 50
- 208000027418 Wounds and injury Diseases 0.000 description 50
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 229940057995 liquid paraffin Drugs 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- HFCUBKYHMMPGBY-UHFFFAOYSA-N 2-methoxyethyl prop-2-enoate Chemical compound COCCOC(=O)C=C HFCUBKYHMMPGBY-UHFFFAOYSA-N 0.000 description 3
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000003484 crystal nucleating agent Substances 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical group COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 229920005604 random copolymer Polymers 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000000472 traumatic effect Effects 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 1
- WROUWQQRXUBECT-UHFFFAOYSA-M 2-ethylacrylate Chemical compound CCC(=C)C([O-])=O WROUWQQRXUBECT-UHFFFAOYSA-M 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010051814 Eschar Diseases 0.000 description 1
- 208000035874 Excoriation Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 208000005422 Foreign-Body reaction Diseases 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 230000008952 bacterial invasion Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 231100000333 eschar Toxicity 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940014041 hyaluronate Drugs 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920005597 polymer membrane Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
Landscapes
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は、創傷被覆材に関するも
のである。詳しく述べると、本発明は創傷、熱傷等によ
る皮膚欠損受傷の際、該皮膚欠損部位に適用され該皮膚
欠損部位と接する面を水和湿潤状態にして、表皮再生を
促進する創傷被覆材に関する。FIELD OF THE INVENTION This invention relates to wound dressings. More specifically, the present invention relates to a wound dressing that is applied to a skin defect site due to a wound, burn, etc., and promotes epidermal regeneration by bringing the surface in contact with the skin defect into a hydrated state.
【0002】0002
【従来の技術】外傷性の皮膚創傷および採皮創等の創傷
および疾患に伴う創部に対する創傷保護の方法および材
料としては、大別して創傷部を乾燥状態に保ち、痂皮形
成した治癒を行う、いわゆるdry dressin
gと、適度の湿潤環境を作成し、速やかな表皮細胞の遊
走を行うwet dressingとが知られており
、後者は創傷の治癒も速やかであり、創傷部表面の乾燥
壊死が少なく、創面の保護効果も有することが知られて
いる。BACKGROUND OF THE INVENTION Methods and materials for protecting wounds such as traumatic skin wounds and skin harvest wounds, as well as wounds associated with diseases, can be roughly divided into two methods: keeping the wound dry and healing it by forming an eschar; So-called dry dress
g, and wet dressing, which creates a moderately moist environment and allows rapid migration of epidermal cells, is known.The latter allows for rapid wound healing, less dry necrosis on the wound surface, and protects the wound surface. It is also known to have beneficial effects.
【0003】しかし、wet dressingの一
方法であるサージカルドレープを用いる方法では、浸出
液の貯留が多く創面に再吸収されるおそれがあり、また
感染の危険も大きく、接着剤が直接創面と接するため、
創治癒に有害と思われる問題があることが指摘されてい
る。また、創面から剥がれやすいこともあり、創面と接
する部分に小さな突起を付けたものもあるが、逆に除去
困難という欠点を有するなどの問題があった。[0003] However, in the method of using a surgical drape, which is one method of wet dressing, a large amount of exudate accumulates and there is a risk that it will be reabsorbed into the wound surface, and there is also a high risk of infection, and because the adhesive comes into direct contact with the wound surface,
It has been pointed out that there are problems that may be detrimental to wound healing. In addition, they tend to peel off from the wound surface, so some products have small protrusions attached to the part that comes into contact with the wound surface, but they have the disadvantage of being difficult to remove.
【0004】これらの問題点を解決するため近年では創
傷部に接触し得る部位にコラーゲン、キチン、フィブリ
ン等の生体高分子を用いるもの、あるいはゴム系の素材
中に保湿成分を分散させ密着・非癒着・高含水状態の確
保などを図ったもの、さらには本件出願人が以前提案し
た創傷部に接触し得る部位の少なくとも一部が撥水性物
質により被覆された生体適合性ヒドロゲル形成性の支持
層(例えば、カルボキシメチルセルロース、アルギン酸
塩系、ヒアルロン酸塩系、ポリ(メタ)アクリル酸塩系
)と、該支持層の創傷部に接触し得る部位とは反対側に
形成された水分透過調節層とからなる創傷被覆材(特開
昭62−183760号公報)等があり、一定の成果を
おさめている。[0004] In order to solve these problems, in recent years, biopolymers such as collagen, chitin, and fibrin are used in areas that can come into contact with the wound, or moisturizing ingredients are dispersed in rubber-based materials to provide adhesive and non-adhesive materials. A biocompatible hydrogel-forming support layer that is designed to ensure adhesion and maintain a high water content state, as well as a biocompatible hydrogel-forming support layer in which at least a portion of the area that can come into contact with the wound area is coated with a water-repellent material, as previously proposed by the applicant. (for example, carboxymethylcellulose, alginate-based, hyaluronate-based, poly(meth)acrylate-based), and a moisture permeation regulating layer formed on the opposite side of the support layer from the part that can come into contact with the wound area. There are wound dressing materials (Japanese Unexamined Patent Application Publication No. 183760/1983) made of these materials, which have achieved a certain degree of success.
【0005】一方、dry dressingとして
多孔質高分子膜があるが、この場合dressingが
創面に固着してしまい剥がす際に出血を伴う為、最近で
は創面と接触する部位には非粘着性多孔フィルム(Me
lolinR,Smith&Nephew Limi
ted)を使用したドレッシングが市販されている。On the other hand, porous polymer membranes are available as dry dressings, but in this case the dressings stick to the wound surface and cause bleeding when removed, so recently non-adhesive porous films ( Me
lolinR, Smith & Nephew Limi
ted) is commercially available.
【0006】また、特開昭58−155854号公報に
見られるように、多孔質フィルムからなる創傷被覆材が
あるが、気孔率が50%以上である為、関節部位等の傷
面に適用した場合、被覆材にひび割れ等がおこり、強度
面では十分ではない。[0006] Furthermore, as seen in JP-A-58-155854, there is a wound dressing made of a porous film, but since the porosity is 50% or more, it cannot be applied to wound surfaces such as joints. In this case, cracks occur in the covering material and the strength is not sufficient.
【0007】[0007]
【発明が解決しようとする課題】上記従来の被覆材もあ
る程度の効果は有しているが、創傷部と接触する部分の
生体適合性を有する基剤層の形成に用いられている材料
が、分解、脱落しやすく、創傷被覆材としての使用時に
おける物性に問題があり、さらに分解・離脱物が異物と
して認識されることがあり、創傷部の治癒を遅延させる
危険性があった。また、支持層の創傷部に接触する部位
とは反対側に形成される水分透過調節層は、適度な水分
透過能と細菌侵入阻止能を有していることが必要とされ
るが、この両者の性質を満足させる材料は、かなり限定
されるものであった。[Problems to be Solved by the Invention] Although the above-mentioned conventional dressings have some effects, the materials used to form the biocompatible base layer in the part that comes into contact with the wound are It easily decomposes and falls off, and there are problems with its physical properties when used as a wound dressing.Furthermore, the decomposed and separated substances are sometimes recognized as foreign substances, and there is a risk of delaying the healing of the wound. In addition, the moisture permeation regulating layer formed on the side of the support layer opposite to the part that contacts the wound area is required to have appropriate moisture permeability and bacterial invasion prevention ability; Materials that satisfy these properties are quite limited.
【0008】そこで、本発明は創面への良好な密着性を
有し、創傷部と接触しても容易に分解、離脱することが
なく、創傷部の治癒、特に表皮再生が促進され、創傷部
の早期の治癒を行うことができ、また多孔質ポリオレフ
ィン膜あるいは多孔質ハロゲン化ポリオレフィン膜が水
蒸気透過性を兼ね備えた創傷被覆材を提供することを目
的とする。Therefore, the present invention has good adhesion to the wound surface, does not easily decompose or come off when it comes into contact with the wound, promotes healing of the wound, especially epidermal regeneration, and improves the wound area. The purpose of the present invention is to provide a wound dressing material that can perform early healing of the wound and in which the porous polyolefin membrane or the porous halogenated polyolefin membrane has water vapor permeability.
【0009】[0009]
【課題を解決するための手段】上記目的は下記の構成を
有する創傷被覆材によって達成される。
1)空孔率50%未満、水蒸気透過率500〜10,0
00g/m2・24hrである多孔質ポリオレフィン膜
あるいは多孔質ハロゲン化ポリオレフィン膜からなる創
傷被覆材。
2)多孔質ポリオレフィン膜あるいは多孔質ハロゲン化
ポリオレフィン膜の少なくとも一方の表面に親水性ポリ
マーを化学的に結合させてなる1項に記載の創傷被覆材
。
3)多孔質ポリオレフィン膜あるいは多孔質ハロゲン化
ポリオレフィン膜にアクリル酸エステルをグラフト重合
させて弾性を付与したものである1項に記載の創傷被覆
材。The above objects are achieved by a wound dressing having the following structure. 1) Porosity less than 50%, water vapor permeability 500-10.0
A wound dressing made of a porous polyolefin membrane or a porous halogenated polyolefin membrane with a weight of 00g/m2/24hr. 2) The wound dressing according to item 1, wherein a hydrophilic polymer is chemically bonded to at least one surface of a porous polyolefin membrane or a porous halogenated polyolefin membrane. 3) The wound dressing material according to item 1, which is obtained by graft polymerizing an acrylic acid ester to a porous polyolefin membrane or a porous halogenated polyolefin membrane to impart elasticity.
【0010】本発明に用いられる膜は多孔質ポリオレフ
ィン膜あるいは多孔質ハロゲン化ポリオレフィン膜であ
り、汎用で低価格な面を考慮すると、ポリエチレン、ポ
リプロピレン、ポリフッ化ビニリデン、ポリ塩化ビニリ
デン、塩素化ポリエチレン、もしくはこれらの共重合体
などが好ましい。得られた被覆材は空孔率50%未満、
より好ましくは40〜48%、水蒸気透過率500〜1
0,000g/m2・24hr、より好ましくは200
0〜5000g/m2・24hrの範囲内にあるものが
よい。[0010] The membrane used in the present invention is a porous polyolefin membrane or a porous halogenated polyolefin membrane, and considering its general purpose and low cost, polyethylene, polypropylene, polyvinylidene fluoride, polyvinylidene chloride, chlorinated polyethylene, Or copolymers thereof are preferred. The resulting coating material has a porosity of less than 50%,
More preferably 40-48%, water vapor transmission rate 500-1
0,000g/m2・24hr, more preferably 200
It is preferable that it be within the range of 0 to 5000g/m2・24hr.
【0011】本発明の創傷被覆材は、上記のように多孔
質ポリオレフィン膜あるいは多孔質ハロゲン化ポリオレ
フィン膜に親水性ポリマーを化学的に結合させたものか
らなり、皮膚欠損部位に接する面を水和潤滑状態にして
、表皮再生を促進することができる。多孔質ポリオレフ
ィン膜あるいは多孔質ハロゲン化ポリオレフィン膜に結
合させる親水性ポリマーとしてはメトキシエチルアクリ
レートあるいはN−ジメチルアクリルアミドなどのN−
置換アクリルアミド重合体があげられ、これらを上記ポ
リオレフィン膜にグラフト重合させることにより化学的
に結合させるポリメトキシエチルアクリレートは生体適
合性に優れており、生体組織と接触しても異物反応が少
ないという利点を有する。The wound dressing of the present invention is made of a porous polyolefin membrane or a porous halogenated polyolefin membrane chemically bound to a hydrophilic polymer as described above, and hydrates the surface in contact with the skin defect site. It is possible to promote epidermal regeneration by providing a lubricated state. The hydrophilic polymer to be bonded to the porous polyolefin membrane or the porous halogenated polyolefin membrane is N- such as methoxyethyl acrylate or N-dimethylacrylamide.
Substituted acrylamide polymers are mentioned, and polymethoxyethyl acrylate, which is chemically bonded by graft polymerization to the above-mentioned polyolefin membrane, has excellent biocompatibility and has the advantage that there is little foreign body reaction when it comes in contact with living tissues. has.
【0012】本発明の創傷被覆材は、このままでも強度
の面においても優れているが、更に物性の向上をはかる
目的でアクリル酸エステルをグラフト重合させることも
可能である。アクリル酸エステルはアクリル酸メチル、
エチル、n−プロピル、iso−プロピル、n−ブチル
またはiso−ブチルがあるが、特に限定する必要もな
い。Although the wound dressing of the present invention is excellent in terms of strength as it is, it is also possible to graft-polymerize an acrylic ester in order to further improve the physical properties. Acrylic ester is methyl acrylate,
Examples include ethyl, n-propyl, iso-propyl, n-butyl or iso-butyl, without particular limitation.
【0013】本発明の創傷被覆材は例えば次のようにし
て製造される。まずプロピレンとエチレンのランダムコ
ポリマーに所定量の流動パラフィン及び結晶核形成剤を
加えて溶融混練しペレット化する。このペレットを15
0〜200℃で溶融し、Tダイ付押出機により押出し、
冷却固定化後、流動パラフィンの抽出を行って、ポリオ
レフィン製の多孔質膜を得る。このようにして得られた
膜の空孔率は以下のようにして測定することができる。The wound dressing of the present invention is manufactured, for example, as follows. First, a predetermined amount of liquid paraffin and a crystal nucleating agent are added to a random copolymer of propylene and ethylene, and the mixture is melt-kneaded and pelletized. 15 of these pellets
Melt at 0 to 200°C and extrude using an extruder with a T die,
After cooling and fixation, liquid paraffin is extracted to obtain a porous membrane made of polyolefin. The porosity of the membrane thus obtained can be measured as follows.
【0014】多孔質膜の膜厚と乾燥重量を測定し、メタ
ノールに浸漬した後、水中でメタノールを置換して取り
出し、表面の水を拭って膜の湿潤重量を測定する。膜厚
と乾燥重量、原料の比重から乾燥空孔率を求める。また
乾燥重量と湿潤重量から湿潤空孔率を求める。本発明に
おいて使用している空孔率は乾燥空孔率である。The thickness and dry weight of the porous membrane are measured, and after immersing it in methanol, the methanol is replaced with water, the membrane is taken out, and the water on the surface is wiped to measure the wet weight of the membrane. Determine the dry porosity from the film thickness, dry weight, and specific gravity of the raw material. In addition, the wet porosity is determined from the dry weight and wet weight. The porosity used in the present invention is dry porosity.
【0015】一方、弾性ポリオレフィン製の多孔質膜を
得るには、ポリオレフィン製の多孔質膜にアクリル酸エ
チルをプラズマ開始表面グラフト重合する。この膜は処
理前のポリオレフィン製の多孔質膜と比較して、強度が
1.5倍、伸度1.8倍以上であった。On the other hand, in order to obtain a porous membrane made of elastic polyolefin, ethyl acrylate is subjected to plasma-initiated surface graft polymerization onto the porous membrane made of polyolefin. The strength of this membrane was 1.5 times higher and the elongation was 1.8 times higher than that of the polyolefin porous membrane before treatment.
【0016】また、ポリオレフィン膜にメトキシエチル
アクリレートあるいはN−ジメチルアクリルアミドなど
のN−置換アクリルアミドをプラズマ開始表面グラフト
重合し、親水化処理したポリオレフィン製の多孔質膜を
得る。この膜は湿潤下で非常にざらつき感が低く、ぬる
ぬるとした水和状態となる。[0016] Furthermore, plasma-initiated surface graft polymerization of N-substituted acrylamide such as methoxyethyl acrylate or N-dimethylacrylamide is performed on a polyolefin membrane to obtain a hydrophilic porous membrane made of polyolefin. When wet, this film has a very low roughness and becomes slimy and hydrated.
【0017】本発明の創傷被覆材は、手や足の関節等の
屈伸する創面に適用することができ、空気や水蒸気は透
過するが、水分や細菌の侵入を防ぐことができる。The wound dressing of the present invention can be applied to bending and stretching wound surfaces such as the joints of hands and feet, and allows air and water vapor to pass therethrough, but prevents moisture and bacteria from entering.
【0018】[0018]
【実施例】以下、実施例を示して本発明をさらに具体的
に説明する。EXAMPLES The present invention will be explained in more detail below with reference to Examples.
【0019】実施例1
プロピレンとエチレンのランダムコポリマー(三井東圧
化学株式会社製)100重量部当り、300重量部の流
動パラフィン(平均分子量324)及び0.3重量部の
結晶核形成剤としての1,3,2,4−ビス(p−エチ
ルベンジリデン)ソルビトールを二軸型押出機により溶
融混練し、ペレット化した。このペレットを上記二軸押
出機を用いて150〜200℃で溶融し、スリット0.
6mmのTダイより空気中に押出しフィルム状にし、こ
のフィルム状物をTダイ直下に置かれたガイドローラー
によって冷却固定化液中に導き冷却固定化した後巻取る
。この巻き取ったフィルム状物を一定寸法に切断し、縦
横両方向に固定し、1,1,2−トリクロロ−1,2,
2−トリフルオロエタン中に10分間計4回浸漬して、
フィルム状物中の流動パラフィンの抽出を行って、空孔
率45%、孔径0.07μmのポリオレフィン製多孔質
膜を得た。Example 1 Per 100 parts by weight of a random copolymer of propylene and ethylene (manufactured by Mitsui Toatsu Chemical Co., Ltd.), 300 parts by weight of liquid paraffin (average molecular weight 324) and 0.3 parts by weight as a crystal nucleating agent were added. 1,3,2,4-bis(p-ethylbenzylidene) sorbitol was melt-kneaded using a twin-screw extruder and pelletized. The pellets were melted at 150 to 200°C using the above-mentioned twin screw extruder, and the slits were 0.
It is extruded into a film through a 6 mm T-die in the air, guided into a cooling fixation liquid by a guide roller placed directly below the T-die, cooled and fixed, and then wound up. This rolled-up film-like material was cut into a certain size, fixed both vertically and horizontally, and 1,1,2-trichloro-1,2,
Immersed in 2-trifluoroethane for 10 minutes 4 times in total,
The liquid paraffin in the film was extracted to obtain a polyolefin porous membrane having a porosity of 45% and a pore diameter of 0.07 μm.
【0020】比較例1
ポリプロピレン粉末(三井東圧化学株式会社製)100
重量部当たり、300重量部の流動パラフィン(平均分
子量324)及び0.3重量部の結晶核形成剤としての
1,3,2,4−ビス(p−エチルベンジリデン)ソル
ビトールを二軸型押出機により溶融混練し、ペレット化
した。このペレットを上記二軸型押出機を用いて150
〜200℃で溶融し、スリット0.6mmのTダイより
空気中に押出しフィルム状にし、このフィルム状物をT
ダイ直下に置かれたガイドローラーによって冷却固定化
液中に導き冷却固定化した後巻取る。この巻取ったフィ
ルム状物を一定寸法に切断し、縦横両方向に固定し、1
,1,2−トリクロロ−1,2,2−トリフルオロエタ
ン中に10分間計4回浸漬して、フィルム状物中の流動
パラフィンの抽出を行う。次いで135℃の空気中で2
分間熱処理を行って、空孔率60%、孔径0.1μmの
ポリプロピレン製多孔質膜を得た。Comparative Example 1 Polypropylene powder (manufactured by Mitsui Toatsu Chemical Co., Ltd.) 100
Per part by weight, 300 parts by weight of liquid paraffin (average molecular weight 324) and 0.3 parts by weight of 1,3,2,4-bis(p-ethylbenzylidene) sorbitol as a crystal nucleating agent were added in a twin-screw extruder. The mixture was melt-kneaded and pelletized. The pellets were processed using the above twin-screw extruder for 150
It is melted at ~200°C and extruded into a film through a T-die with a slit of 0.6 mm into a film.
It is guided into a cooling fixation liquid by a guide roller placed directly under the die, cooled and fixed, and then wound up. This rolled-up film-like material is cut into a certain size, fixed in both vertical and horizontal directions, and
, 1,2-trichloro-1,2,2-trifluoroethane for a total of 4 times for 10 minutes to extract the liquid paraffin in the film. Then, in air at 135°C,
A heat treatment was performed for a minute to obtain a polypropylene porous membrane with a porosity of 60% and a pore diameter of 0.1 μm.
【0021】実施例2
実施例1で得られた膜にアクリル酸エチルをプラズマ開
始表面グラフト重合し、弾性を付与したポリオレフィン
製多孔質膜を得た。即ち、多孔膜に0.1Torr、1
5秒アルゴンプラズマを照射した後、アクリル酸エチル
雰囲気中で(25℃、4Torr)、30分グラフト重
合を行なった。得られたアクリル酸エチルグラフト化多
孔質膜は空孔率42%であった。Example 2 Ethyl acrylate was subjected to plasma-initiated surface graft polymerization to the membrane obtained in Example 1 to obtain a polyolefin porous membrane imparted with elasticity. That is, the porous membrane was heated to 0.1 Torr, 1
After irradiating with argon plasma for 5 seconds, graft polymerization was carried out for 30 minutes in an ethyl acrylate atmosphere (25° C., 4 Torr). The resulting ethyl acrylate grafted porous membrane had a porosity of 42%.
【0022】実施例3
実施例1で得られたメトキシエチルアクリレートを実施
例2と同様な方法でプラズマ開始表面グラフト重合し親
水化した多孔質膜を得た。Example 3 The methoxyethyl acrylate obtained in Example 1 was subjected to plasma-initiated surface graft polymerization in the same manner as in Example 2 to obtain a hydrophilic porous membrane.
【0023】試験1
<各種創傷被覆材の物性試験>実施例1,2,3および
比較例1で得られた多孔質膜について、引張り強度(ス
トログラフT型、東洋精機製作所)を測定した。結果を
表1に示す。Test 1 <Physical property test of various wound dressing materials> The tensile strength (Strograph T type, Toyo Seiki Seisakusho) of the porous membranes obtained in Examples 1, 2, and 3 and Comparative Example 1 was measured. The results are shown in Table 1.
【0024】[0024]
【表1】[Table 1]
【0025】実施例1〜3では比較例に比べて破断強度
、破断伸度においてすぐれていた。Examples 1 to 3 were superior in breaking strength and breaking elongation as compared to comparative examples.
【0026】試験2
〈水分透過試験〉シャーレ内のスポンジに蒸留水を十分
含ませた後、その表面に実施例3と比較例1の多孔質膜
を載せ、その上に8枚ガーゼを重ねた。ついでシャーレ
の蓋と重し(約5g)で圧迫した後、これを室温に放置
した。ガーゼの重量を経時的に精量して測定した。結果
を図1に示す。図1において、○−○は実施例3、●−
●は比較例1におけるガーゼの水分含有量を示す。図1
の結果より、実施例3は水分透過性が非常に高いことが
わかった。Test 2 <Water permeation test> After sufficiently soaking a sponge in a Petri dish with distilled water, the porous membranes of Example 3 and Comparative Example 1 were placed on its surface, and 8 sheets of gauze were placed on top of it. . Then, after pressing with a Petri dish lid and a weight (approximately 5 g), this was left at room temperature. The weight of the gauze was accurately measured over time. The results are shown in Figure 1. In Figure 1, ○-○ is Example 3, ●-
● indicates the water content of the gauze in Comparative Example 1. Figure 1
From the results, it was found that Example 3 had very high moisture permeability.
【0027】試験3
〈水蒸気透過試験〉水蒸気透過試験はJIS規格(Z
0208)により測定した。結果を表2に示す。Test 3 <Water vapor permeation test> The water vapor permeation test is based on the JIS standard (Z
0208). The results are shown in Table 2.
【0028】[0028]
【表2】[Table 2]
【0029】[0029]
【発明の効果】本発明の創傷被覆材は熱傷、採皮創およ
び皮膚剥削傷、外傷性皮膚欠損創等の疾患ないし、創傷
による患部、特に手や足の関節等の屈伸する創面に適用
することができ、また親水化処理することによって、適
当な水分透過性と創面との接触面を水和潤滑状態にして
、創面に密着し表皮再生を促進することができる。[Effects of the Invention] The wound dressing of the present invention can be applied to diseases such as burns, skin harvest wounds, skin abrasion wounds, traumatic skin loss wounds, and affected areas caused by wounds, especially wound surfaces that bend and stretch such as the joints of hands and feet. In addition, by hydrophilic treatment, the surface in contact with the wound surface can be made into a hydrated and lubricated state with appropriate water permeability, allowing it to adhere closely to the wound surface and promote epidermal regeneration.
【図1】多孔質膜の上に重ねたガーゼの水分含有量の経
時的変化を示すグラフである。FIG. 1 is a graph showing changes over time in the water content of gauze layered on a porous membrane.
○−○ 実施例3
●−● 比較例1におけるガーゼの水分含有量の経時
的変化○−○ Example 3 ●−● Change in water content of gauze over time in Comparative Example 1
Claims (3)
0〜10,000g/m2・24hrである多孔質ポリ
オレフィン膜および/または多孔質ハロゲン化ポリオレ
フィン膜からなる創傷被覆材。[Claim 1] Porosity less than 50%, water vapor permeability 50
A wound dressing consisting of a porous polyolefin membrane and/or a porous halogenated polyolefin membrane having a weight of 0 to 10,000 g/m2/24 hr.
は多孔質ハロゲン化ポリオレフィン膜の一方の表面に親
水性ポリマーを化学的に結合させてなる請求項1に記載
の創傷被覆材。2. The wound dressing according to claim 1, wherein a hydrophilic polymer is chemically bonded to one surface of a porous polyolefin membrane and/or a porous halogenated polyolefin membrane.
は多孔質ハロゲン化ポリオレフィン膜にアクリル酸エス
テルをグラフト重合させて弾性を付与したものである請
求項1に記載の創傷被覆材。3. The wound dressing material according to claim 1, wherein elasticity is imparted to the porous polyolefin membrane and/or the porous halogenated polyolefin membrane by graft polymerization of an acrylic acid ester.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11123791A JPH04263854A (en) | 1991-02-19 | 1991-02-19 | Wound coating material |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11123791A JPH04263854A (en) | 1991-02-19 | 1991-02-19 | Wound coating material |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04263854A true JPH04263854A (en) | 1992-09-18 |
Family
ID=14556051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP11123791A Pending JPH04263854A (en) | 1991-02-19 | 1991-02-19 | Wound coating material |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04263854A (en) |
-
1991
- 1991-02-19 JP JP11123791A patent/JPH04263854A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0091800B2 (en) | Surgical adhesive dressing | |
US4798201A (en) | Surgical adhesive dressing | |
AU643058B2 (en) | Wound-covering materials | |
EP0327328B1 (en) | Adhesive-faced porous absorbent sheet and method of making same | |
Bruin et al. | A new porous polyetherurethane wound covering | |
JP2020503392A (en) | Breathable film with microbial barrier properties | |
US4803078A (en) | Wound dressing | |
JP2002523565A (en) | Naturally antibacterial quaternary amine hydrogel wound dressing | |
JPS6317458B2 (en) | ||
US5098500A (en) | Adhesive-faced porous absorbent sheet and method of making same | |
KR20030060458A (en) | Method for the preparation of hydrogels for wound dressings | |
JPH04303445A (en) | Wound covering material | |
JPH04263854A (en) | Wound coating material | |
JP2006271927A (en) | Wound covering composition and sheet-like wound covering material | |
JPH05192363A (en) | Wound covering material | |
JPH04135565A (en) | Artificial skin | |
WO2021187619A1 (en) | Structure reinforcing material | |
JP2896216B2 (en) | Wound dressing | |
EP0470007B1 (en) | Wound-covering materials | |
JPH05192386A (en) | Wound covering material | |
JP2896210B2 (en) | Wound dressing | |
JPH08322874A (en) | Biocompatible tacky adhesive pad | |
Reed | Mitraflex: development of an intelligent, spyrosorbent wound dressing | |
JPS5852662B2 (en) | Seizouhou | |
JPS63115566A (en) | Wound cover material |